170 related articles for article (PubMed ID: 12907899)
21. [Clinical significance of tumor budding detection in stage II colon cancer].
Liu SJ; Yang XH; Ren JQ; Zhu XJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Aug; 16(8):730-4. PubMed ID: 23980042
[TBL] [Abstract][Full Text] [Related]
22. Incidence, Patterns, and Predictors of Locoregional Recurrence in Colon Cancer.
Liska D; Stocchi L; Karagkounis G; Elagili F; Dietz DW; Kalady MF; Kessler H; Remzi FH; Church J
Ann Surg Oncol; 2017 Apr; 24(4):1093-1099. PubMed ID: 27812826
[TBL] [Abstract][Full Text] [Related]
23. Histologic prognostic markers in stage IIA colorectal cancer: a comparative study.
Barresi V; Reggiani Bonetti L; Ieni A; Branca G; Tuccari G
Scand J Gastroenterol; 2016 Mar; 51(3):314-20. PubMed ID: 26554618
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological risk factors of Stage II colon cancer: results of a prospective study.
Santos C; López-Doriga A; Navarro M; Mateo J; Biondo S; Martínez Villacampa M; Soler G; Sanjuan X; Paules MJ; Laquente B; Guinó E; Kreisler E; Frago R; Germà JR; Moreno V; Salazar R
Colorectal Dis; 2013 Apr; 15(4):414-22. PubMed ID: 22974322
[TBL] [Abstract][Full Text] [Related]
25. Budding is useful to select high-risk patients in stage II well-differentiated or moderately differentiated colon adenocarcinoma.
Okuyama T; Nakamura T; Yamaguchi M
Dis Colon Rectum; 2003 Oct; 46(10):1400-6. PubMed ID: 14530682
[TBL] [Abstract][Full Text] [Related]
26. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
[TBL] [Abstract][Full Text] [Related]
27. Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer.
Ghosh P; Tie J; Muranyi A; Singh S; Brunhoeber P; Leith K; Bowermaster R; Liao Z; Zhu Y; LaFleur B; Tran B; Desai J; Jones I; Croxford M; Jover R; Goel A; Waring P; Hu S; Teichgraber V; Rohr UP; Ridder R; Shanmugam K; Gibbs P
Clin Cancer Res; 2016 Jul; 22(14):3488-98. PubMed ID: 27029492
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with early recurrence after curative surgery for gastric cancer.
Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
[TBL] [Abstract][Full Text] [Related]
29. Effects of allogeneic blood transfusion in patients with stage II colon cancer.
Meng J; Lu XB; Tang YX; Sun GP; Li X; Yan YF; Liang GF; Ma SP; Li XX
Asian Pac J Cancer Prev; 2013; 14(1):347-50. PubMed ID: 23534751
[TBL] [Abstract][Full Text] [Related]
30. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.
Bowne WB; Lee B; Wong WD; Ben-Porat L; Shia J; Cohen AM; Enker WE; Guillem JG; Paty PB; Weiser MR
Dis Colon Rectum; 2005 May; 48(5):897-909. PubMed ID: 15785892
[TBL] [Abstract][Full Text] [Related]
31. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
[TBL] [Abstract][Full Text] [Related]
32. Predictive factor of recurrence after curative resection for stage I-II colon cancer.
Dougaz W; Bouasker I; Gouta EL; Khalfallah M; Oueslati A; Samaali I; Ghariani W; Jerraya H; Nouira R; Dziri C
Tunis Med; 2019 May; 97(5):685-691. PubMed ID: 31729741
[TBL] [Abstract][Full Text] [Related]
33. Long-term results of curative resection of "minimally invasive" colorectal cancer.
Hase K; Shatney CH; Mochizuki H; Johnson DL; Tamakuma S; Vierra M; Trollope M
Dis Colon Rectum; 1995 Jan; 38(1):19-26. PubMed ID: 7813339
[TBL] [Abstract][Full Text] [Related]
34. Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon.
Skancke M; Arnott SM; Amdur RL; Siegel RS; Obias VJ; Umapathi BA
Dis Colon Rectum; 2019 Feb; 62(2):181-188. PubMed ID: 30640833
[TBL] [Abstract][Full Text] [Related]
35. Is there no need to discuss adjuvant chemotherapy in stage II colon cancer patients with high tumor budding and lymphovascular invasion?
Zenger S; Gurbuz B; Can U; Erginoz E; Ozata IH; Yilmaz SP; Taskin OC; Peker O; Adsay V; Balik E; Bugra D
Langenbecks Arch Surg; 2023 Mar; 408(1):127. PubMed ID: 36973561
[TBL] [Abstract][Full Text] [Related]
36. [Risk factors for tumor recurrence after curative resection in patients with Stage IIIa colon and rectosigmoid cancer].
Shigemasa Y; Oyama S; Hashimoto Y; Kusaba T; Kajihara K; Sasaki N; Ikari H; Kunizaki T; Yonemitsu N
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2053-5. PubMed ID: 24394010
[TBL] [Abstract][Full Text] [Related]
37. High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer.
Park JS; Chon HJ; Jeung HC; Shin SJ; Rha SY; Ahn JB; Lee KY; Kim NK; Chung HC
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2051-9. PubMed ID: 27447697
[TBL] [Abstract][Full Text] [Related]
38. Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy.
Law WL; Ho JW; Chan R; Au G; Chu KW
Dis Colon Rectum; 2005 Feb; 48(2):218-26. PubMed ID: 15711860
[TBL] [Abstract][Full Text] [Related]
39. Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer.
Lee VWK; Chan KF
Pathol Res Pract; 2018 Mar; 214(3):402-407. PubMed ID: 29487008
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic risk factors associated with recurrence after curative resection in patients with stage II colorectal cancer].
Koyama M; Morita T; Hashizume T; Ito S; Tohyama S; Inaba Y; Oishi S; Morohashi H; Sakamoto Y; Murata A; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1650-2. PubMed ID: 24393877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
